Replacing Wood Stoves Could Save $66 Billion In Healthcare Costs Annually
Implementing adequate policies to replace wood and charcoal burning stoves could prevent at least 463,000 deaths and $66 billion in healthcare costs yearly in sub-Saharan Africa, according to a recent study published in the journal Nature Sustainability. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 13, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Prevalence and determinants of falls in community-dwelling older adults in T ürkiye: a population-based cross-sectional study conducted between 2014-2015 - Catikkas NM, Erdogan TO, Reginster JY, Oren MM, Aydin CO, Sacar DE, Ozkok S, Kilic C, Karan MA, Bahat G.
We present a field study c... (Source: SafetyLit)
Source: SafetyLit - January 13, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Rapid MRI protocol leads to reduced image acquisition times
A rapid lumbar MRI protocol that uses 3D imaging and deep learning reconstructio...Read more on AuntMinnie.comRelated Reading:
Reducing use of sedation for pediatric MRI cuts healthcare costs
Ultrafast MRI shows promise in predicting DCIS upstaging
Ultrafast DCE-MRI helps predict breast cancer treatment response
Is abbreviated MRI useful for women at average breast cancer risk?
Rapid MRI for ED stroke evaluation cuts costs, hospital length of stay (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 6, 2023 Category: Radiology Source Type: news
Timing of Instillation Therapy and NPWT Outcomes and Costs Timing of Instillation Therapy and NPWT Outcomes and Costs
Earlier initiation of NPWT with instillation may result in lower healthcare costs and better patient outcomes.Wounds (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 6, 2023 Category: Surgery Tags: General Surgery Journal Article Source Type: news
Suicide among older Hispanic adults: a call to action - Yockey RA, Vidourek R, King K.
In 2020, suicide was the 12th leading cause of death in the United States (Garnett et al., 2022). Suicide contributes to high healthcare costs and accounts for numerous emergency department visits. The United States' Healthy People 2030 Initiative has outl... (Source: SafetyLit)
Source: SafetyLit - January 2, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Reducing use of sedation for pediatric MRI cuts healthcare costs
Reducing the use of sedation for pediatric brain MRI exams translates into "substantia...Read more on AuntMinnie.comRelated Reading:
MRI reveals link between obesity, poor pediatric brain health
MRI markers show racial disparities in brain health
RANZCR highlights brain MRI findings in space study
Could MRI help detect brain metastases from breast cancer?
Brain MRI shows that boxers regain brain health postcareer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 22, 2022 Category: Radiology Source Type: news
Rate and causes of inappropriate stays and the resulting financial burden in a single specialty burns hospital - Moradi N, Moradi K, Bagherzadeh R, Aryankhesal A.
BACKGROUND: One of the most important challenges facing hospitals is inappropriate admissions and stays the reduction of which can contribute to a decline in healthcare costs without reducing the quality of services. The aim of this study was to estimate t... (Source: SafetyLit)
Source: SafetyLit - December 19, 2022 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Updated data from the phase III POLARIX study continue to demonstrate a statistically significant reduction in the risk of disease worsening or death for people with previously untreated diffuse large B-cell lymphoma (DLBCL)1Patients receivingPolivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes, during and after fixed-duration treatment, to those receiving the current standard-of-care, withsuperiorprogression-free survival2Basel, 12 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new and updated data for its first-in-class anti-CD79b antibody-drug conjugate Polivy ® ...
Source: Roche Media News - December 12, 2022 Category: Pharmaceuticals Source Type: news
Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Updated data from the phase III POLARIX study continue to demonstrate a statistically significant reduction in the risk of disease worsening or death for people with previously untreated diffuse large B-cell lymphoma (DLBCL)1Patients receivingPolivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes, during and after fixed-duration treatment, to those receiving the current standard-of-care, withsuperiorprogression-free survival2Basel, 12 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new and updated data for its first-in-class anti-CD79b antibody-drug conjugate Polivy ® ...
Source: Roche Investor Update - December 12, 2022 Category: Pharmaceuticals Source Type: news
A Bold National Plan to Eliminate HCV by 2050 A Bold National Plan to Eliminate HCV by 2050
If implemented as proposed by three preeminent scientists, the ambitious program would save many thousands of lives, and nearly $60 billion in future healthcare costs.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - December 9, 2022 Category: Respiratory Medicine Tags: Gastroenterology News Source Type: news
Utilization of torso computed tomography for the evaluation of ground level falls: more imaging does not equal better care - Zhu M, O'Brien M, Shaikh SP, Brahmbhatt TS, LeBedis C, Scantling D, Sanchez SE.
INTRODUCTION: Computed tomography (CT) of the chest (CTC), abdomen, and pelvis (CTAP) is common when assessing trauma patients in the emergency department. However, unnecessary imaging can expose patients to unneeded radiation and increase healthcare costs... (Source: SafetyLit)
Source: SafetyLit - December 7, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Where does YOUR state rank? Hospital wait times and healthcare costs revealed
If you have an emergency, then you probably don't want to be in Maryland. Data shows this state has the longest waits in its emergency room nationwide, at nearly four hours. (Source: the Mail online | Health)
Source: the Mail online | Health - December 2, 2022 Category: Consumer Health News Source Type: news
A Cost-Effective De-escalation Strategy in Advanced Melanoma A Cost-Effective De-escalation Strategy in Advanced Melanoma
Response-adapted de-escalation of ipilimumab in patients with advanced melanoma has the potential to lower healthcare costs.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 31, 2022 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Early treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile
77% of early-stage relapsing-remitting multiple sclerosis (RRMS) patients who had not received prior treatment achieved no evidence of disease activity (NEDA) at two yearsInitiation of OCREVUS as first-line treatment reduces relapses,hospitalisations and costs compared with using OCREVUS in second-line settingNine-year long-term safety data for OCREVUS further reinforcefavourable benefit-risk profile; more than 250,000 people have been treated globallyPregnancy outcomes reported for more than 2,000 women with multiple sclerosis (MS) treated with OCREVUS do not suggest an increased risk of adverse pregnancy and infant outco...
Source: Roche Media News - October 26, 2022 Category: Pharmaceuticals Source Type: news
Early treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile
77% of early-stage relapsing-remitting multiple sclerosis (RRMS) patients who had not received prior treatment achieved no evidence of disease activity (NEDA) at two yearsInitiation of OCREVUS as first-line treatment reduces relapses,hospitalisations and costs compared with using OCREVUS in second-line settingNine-year long-term safety data for OCREVUS further reinforcefavourable benefit-risk profile; more than 250,000 people have been treated globallyPregnancy outcomes reported for more than 2,000 women with multiple sclerosis (MS) treated with OCREVUS do not suggest an increased risk of adverse pregnancy and infant outco...
Source: Roche Investor Update - October 26, 2022 Category: Pharmaceuticals Source Type: news
